Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Sclc”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT00544674
What this trial is testing

PR104 in Treating Patients With Previously Untreated or Relapsed Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Proacta, Incorporated 5
Testing effectiveness (Phase 2)Ended earlyNCT00299390
What this trial is testing

Safety and Efficacy Study of a New Chemotherapy Agent to Treat Small Cell Lung Cancer

Who this might be right for
Small Cell Lung Carcinoma
Bayer 10
Testing effectiveness (Phase 2)Ended earlyNCT04352413
What this trial is testing

PLM60 in Subjects With Relapsed Small-cell Lung Cancer After Platinum-based First-Line Chemotherapy

Who this might be right for
Small Cell Lung Cancer
CSPC ZhongQi Pharmaceutical Technology Co., Ltd. 45
Testing effectiveness (Phase 2)Looking for participantsNCT04992780
What this trial is testing

Comparing Hypo-fractionated Intensity- Modulated Radiation Therapy to Standard- Fractionated IMRT Along With Chemotherapy and Immunotherapy for Non-Small Cell Lung Cancer

Who this might be right for
Non Small Cell Lung Cancer Stage
University of Kansas Medical Center 50
Testing effectiveness (Phase 2)Study completedNCT01636934
What this trial is testing

Minocycline Study in Non Small Cell Lung Cancer (NSCLC) Patients for Chemoradiation Therapy

Who this might be right for
Lung Cancer
M.D. Anderson Cancer Center 51
Not applicableUnknownNCT02736916
What this trial is testing

HS-WBRT for Prophylactic Cranial Irradiation in Limited Stage Small Cell Lung Cancer

Who this might be right for
Carcinoma, Small Cell Lung
General Hospital of Ningxia Medical University 3
Large-scale testing (Phase 3)Active Not RecruitingNCT05132075
What this trial is testing

Study of JDQ443 in Comparison With Docetaxel in Participants With Locally Advanced or Metastatic KRAS G12C Mutant Non-small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung Cancer
Novartis Pharmaceuticals 95
Early research (Phase 1)UnknownNCT05829057
What this trial is testing

The IIT Study of Evaluation of P-IL-2 Single Agent and With Anti-PD-1

Who this might be right for
Esophagus CancerBladder CancerLiver Cancer+2 more
Zhejiang University 10
Large-scale testing (Phase 3)UnknownNCT00055965
What this trial is testing

Hospitalization Rates of Patients With Non-Small Cell Lung Cancer Treated With Gemcitabine and Either Cisplatin or Carboplatin

Who this might be right for
Lung Cancer
The Christie NHS Foundation Trust 400
Not applicableStudy completedNCT01928836
What this trial is testing

Risk Stratification of Patients Using the Lung Cancer Biomarker Panel in China

Who this might be right for
Lung Neoplasms
Bai Chunxue 764
Not applicableStudy completedNCT01741636
What this trial is testing

Survivorship Care Planning in Patients With Colorectal or Non-Small Cell Lung Cancer

Who this might be right for
Stage I Colon CancerStage I Rectal CancerStage IA Non-small Cell Lung Cancer+17 more
City of Hope Medical Center 30
Not applicableStudy completedNCT01598597
What this trial is testing

An Observational Pilot Study Evaluating the Feasibility of Conducting Genome-Wide Association Studies Utilizing Subject Provided Information in Subjects With Locally Recurrent or MBC, MCRC, MNSCLC, RGBM or MRCC Treated With Avastin (Bevacizumab) (InVite)

Who this might be right for
Breast CancerColorectal CancerNon-Small Cell Lung Cancer+2 more
Genentech, Inc. 276
Testing effectiveness (Phase 2)UnknownNCT01170923
What this trial is testing

FDG-PET Scan Response Guided Chemotherapy Strategy for Advanced Non-small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
Asan Medical Center 100
Early research (Phase 1)Ended earlyNCT03927573
What this trial is testing

Study With Bispecific Antibody Engaging T-cells, in Patients With Progressive Cancer Diseases With Positive PSCA Marker

Who this might be right for
Non-small Cell Lung CancerProstate CancerRenal Cancer+1 more
AvenCell Europe GmbH 23
Not applicableUnknownNCT06564870
What this trial is testing

Efficacy and Safety Study of DURVALUMAB Maintenance in Patients With Stage III Non-Small Cell Lung Cancer

Who this might be right for
Bronchial Cancer
University Hospital, Brest 200
Not applicableUnknownNCT01240369
What this trial is testing

Association Between VEGF-C and miRNA and Clinical Non-small Cell Lung Cancer and Esophagus Squamous Cell Carcinoma

Who this might be right for
VEGFC Protein in SerumVEGFC Protein in Non Small Cell Lung CancerVEGFC Protein in ESCC+2 more
China Medical University Hospital 250
Testing effectiveness (Phase 2)UnknownNCT04542369
What this trial is testing

Pilot Study of PD-1inhibitor (Tislelizumab) Plus Chemotherapy as Neoadjuvant Therapy for Limited-Stage Small-Cell Lung Cancer

Who this might be right for
Small-cell Lung Cancer
Shanghai Pulmonary Hospital, Shanghai, China 15
Large-scale testing (Phase 3)Study completedNCT00003869
What this trial is testing

Carboxyamidotriazole in Treating Patients With Stage III or Stage IV Non-small Cell Lung Cancer

Who this might be right for
Stage IIIA Non-small Cell Lung CancerStage IIIB Non-small Cell Lung CancerStage IV Non-small Cell Lung Cancer
National Cancer Institute (NCI) 186
Large-scale testing (Phase 3)Study completedNCT01652469
What this trial is testing

Testing of Drugs Erlotinib and Docetaxel in Lung Cancer Patients Classified Regarding Their Outlook Using VeriStrat®.

Who this might be right for
Carcinoma, Non-Small-Cell Lung
ETOP IBCSG Partners Foundation 81
Testing effectiveness (Phase 2)Study completedNCT03535740
What this trial is testing

Brigatinib in Participants With Anaplastic Lymphoma Kinase-Positive (ALK+), Advanced Non-Small-Cell Lung Cancer (NSCLC) Progressed on Alectinib or Ceritinib

Who this might be right for
ALK-positive Advanced NSCLC
Ariad Pharmaceuticals 103
Next Page